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Summary
Background:  Antibiotic  resistance  is  increasing  in  many  community  settings.  The
purpose  of  this  study  was  to  determine  the  proportion  of  antibiotic  resistant
community-associated  bloodstream  infections  (CA-BSIs)  present  on  hospital  admis-
sions  to  identify  risk  factors  for  acquiring  resistant  versus  susceptible  CA-BSIs  and
to  describe  the  incidence  of  concurrent  infections  with  CA-BSIs.
Methods:  We  conducted  a  retrospective  cohort  study  of  patients  discharged  from
one  community,  one  pediatric,  and  two  tertiary/quaternary  care  hospitals  within  an
academically  afﬁliated  network  in  the  borough  of  Manhattan  in  New  York,  NY,  from
2006  to  2008.  The  CA-BSIs  present  at  hospital  admission  were  deﬁned  as  BSIs  occur-
ring  within  the  ﬁrst  48  h  of  hospitalization.  Infections  and  patient  characteristics
were  identiﬁed  using  data  available  from  patients’  electronic  medical  records  and
discharge  records.
Results:  In  total,  1677  CA-BSIs  were  identiﬁed.  Staphylococcus  aureus  had  the
largest  proportion  of  resistance  (41.2%),  followed  by  enterococcal  species  (24.3%),
Pseudomonas  aeruginosa  (20.2%),  Streptococcus  pneumoniae  (16.6%),  Acinetobacter
baumannii  (10.0%),  and  Klebsiella  pneumoniae  (9.9%).  Signiﬁcant  predictors  of  resis-
tance  were  prior  residence  in  a skilled  nursing  facility  (OR,  2.55;  95%  CI,  1.39—4.70),
advanced  age  (1.01;  1.002—1.02),  presence  of  malignancy  (0.58;  0.37—0.91),  prior
hospitalization  (1.62;  1.17—2.23),  a  weighted  Charlson  score  (1.09;  1.02—1.17)  for
S.  aureus,  presence  of  malignancy  (1.82;  1.004—3.30),  prior  hospitalizations  (2.03;
1.12—3.38)  for  enterococcal  species,  and  younger  age  for  S.  pneumoniae  (p  =  0.02).
Urinary  tract  infections  were  the  most  common  concurrent  infection  (n  =  45/87,
51.7%).
∗ Corresponding author at: 630 West 168th Street, New York, NY 10032, USA. Tel.: +1 212 342 4111; fax: +1 212 305 0722.
E-mail addresses: cmw2188@columbia.edu (C.M. Wolfe), bac2116@columbia.edu (B. Cohen), ell23@columbia.edu (E. Larson).
http://dx.doi.org/10.1016/j.jiph.2014.01.001
1876-0341/© 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.
Antibiotic-resistant  community-associated  bloodstream  infections  225
Conclusion:  Over  27%  of  the  CA-BSIs  present  on  admission  were  antibiotic  resistant.
Understanding  the  prevalence  and  risk  factors  for  CA-BSIs  may  help  improve  empiric
antibiotic  therapy  and  outcomes  for  patients  with  community-onset  infections.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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urine microscopy  results,  and  ICD-9-CM  billing
codes to  identify  infections  and  antimicrobial
susceptibilities  for  the  following  organisms  ofLtd.  All  rights  reserved.
ntroduction
ommunity-associated  bloodstream  infections  (CA-
SIs) are  a  major  cause  of  morbidity  and  mortality
orldwide. While  few  population-based  studies
ave characterized  the  epidemiology  of  CA-BSIs
1],  two  recent  estimates  from  Denmark  and
he United  States  suggest  that  the  incidence  is
8 and  83  per  100,000,  respectively,  account-
ng for  approximately  half  of  all  bloodstream
nfections  [2,3]. In  industrialized  nations,  hospi-
alization  following  onset  of  a  CA-BSI  is  common,
nd case  fatality  rates  are  high  at  approximately
3—14% [4,5].  Mortality  can  be  even  greater  for
atients with  an  antibiotic-resistant  CA-BSI  due
o delayed  administration  of  effective  antibiotics
6].  Risk  factors  for  antibiotic  resistance  among
ealthcare-associated  infections  have  been  well
tudied,  with  chronic  conditions  such  as  cancer,
enal and  liver  failure,  invasive  procedures  such  as
urgery, catheterization  and  intubation,  antibiotic
se, and  prolonged  contact  with  healthcare  facil-
ties exhibiting  strong  positive  associations  with
esistance  for  many  different  organisms,  including
taphylococcus  aureus,  Enterococcus  species,  and
ram-negative  bacilli  [7]. However,  factors  associ-
ted with  resistance  among  community-associated
nfections  may  be  different.  Understanding  the
revalence  of  antibiotic  resistance  in  CA-BSIs,
s well  as  which  patients  are  at  highest  risk
f acquiring  a  resistant  CA-BSI,  could  help  to
mprove empiric  antibiotic  therapy  and,  conse-
uently,  patient  outcomes.  Thus,  the  purpose  of
his study  was  to  describe  the  prevalence  of antibi-
tic resistance  in  patients  hospitalized  with  a
A-BSI to  determine  patient  characteristics  asso-
iated  with  acquiring  an  antibiotic-resistant  versus
ntibiotic-susceptible  CA-BSI  and  to  assess  the  inci-
ence of  concurrent  infections  in  other  body  sites
or patients  with  CA-BSIs.
ethodsample and setting
ata  were  collected  from  all  inpatients  discharged
rom four  hospitals  within  a  large  healthcare
i
r
S
nystem  in  the  New  York  metropolitan  area  between
anuary 1,  2006,  and  December  31,  2008.  The
our facilities  included  a  220-bed  community  hos-
ital, a 280-bed  pediatric  acute  care  hospital,  and
wo tertiary/quaternary  care  hospitals  with  650
nd 850  beds,  which  serve  a  diverse  spectrum  of
atients.  This  study  was  approved  by  the  Institu-
ional  Review  Board  of  Columbia  University  Medical
enter.
ata collection
lectronically  stored  data  were  extracted  from  the
linical data  warehouse,  the  admission,  discharge,
ransfer and  billing  system,  and  the  electronic
ealth record  system  shared  by  the  four  hospitals.  A
atabase was  compiled  using  information  from  (1)
aboratory reports,  including  microbiologic  results
rom blood,  urine,  respiratory,  and  wound  cul-
ures; (2)  International  Classiﬁcation  of  Diseases,
inth  Revision,  Clinical  Modiﬁcation  (ICD-9-CM)
iagnosis and  procedure  codes,  including  conditions
resent  on  admission,  procedures  performed,  and
ischarge  diagnoses;  (3)  clinical  records  document-
ng medication  administration  and  catheter  use;
nd (4)  administrative  records  including  age,  race,
dmission  and  discharge  dates,  and  previous  hospi-
alizations within  the  system  [8].
easures
sing  electronically  available  data,  a  team  of
linicians  and  researchers  developed  and  validated
lectronic  algorithms  to  identify  bloodstream,
rinary tract,  respiratory  tract,  and  surgical
ite infections  based  on  the  Centers  for  Dis-
ase Control  and  Prevention  National  Healthcare
afety Network  deﬁnitions  (http://www.cdc.gov/
hsn/about.html). The  algorithms,  described
reviously [8—10], utilized  time-stamped  micro-
iologic  results,  documented  clinical  symptoms,nterest,  which  are  known  to  cause  antibiotic-
esistant BSIs  in  the  United  States:  S.  aureus,
treptococcus  pneumoniae, Klebsiella  pneumo-
iae, Pseudomonas  aeruginosa, enterococcal
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Table  1  Antimicrobial  resistance  in  the  six  organisms
of  interest.
Staphylococcus  aureus  Oxacillin
Streptococcus  pneumoniae  Penicillin
Pseudomonas  aeruginosa  Levoﬂoxacin
Klebsiella  pneumoniae  Imipenem,  Meropenem
Enteroccous  faecalis,
Enterococcus  faecium
Vancomycin
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pneumoniae, where  age  >65  was  negatively  asso-Acinetobacter  baumannii Ampicillin—sulbactam
species  (Enteroccous  faecalis  and  Enterococcus
faecium), and  Acinetobacter  baumannii  [11,12].
Deﬁnitions of  antimicrobial  resistance  for  each
organism  are  summarized  in  Table  1.  Community-
associated infections  were  deﬁned  as  occurring
on or  before  the  patient’s  second  day  of  hospi-
talization. Patients  who  had  been  hospitalized
in the  network  within  the  previous  30  days  and
patients who  developed  a  BSI  after  being  in  the
hospital for  at  least  48  h  were  considered  to  have
healthcare-associated  infections  and  excluded
from further  analysis  [13].
Patients’ demographic  characteristics,  prior  con-
tact with  healthcare  facilities,  and  health  status
at the  time  of  hospital  admission  were  also  col-
lected. Demographic  information  included  age  (<5,
5—12, 13—18,  19—35,  36—50,  51—65,  and  >65
years) and  race  (white,  black,  Hispanic,  other,
or unidentiﬁed).  Prior  contact  with  healthcare
facilities included  ever  having  been  hospitalized
within the  network  (yes/no)  and  having  a  previ-
ously documented  residence  in  a  skilled  nursing
facility (yes/no).  Health  status  at  time  of  hospital
admission was  determined  based  on  present-on-
admission ICD-9-CM  codes  and  included  diagnoses
of diabetes  mellitus,  dermatitis,  renal  failure,  and
malignancies  (yes/no);  history  of  trauma,  dialy-
sis, and  transplant  (yes/no);  and  weighted  Charlson
comorbidity  index  (continuous).
Statistical analyses
All  patients  with  a  CA-BSI  were  included  in  the
analyses. The  primary  outcome  of  interest  was  the
occurrence  of  antibiotic-resistant  CA-BSIs  versus
antibiotic  sensitive  CA-BSIs  of  the  same  organism.
First, the  proportion  of  antibiotic-resistant  CA-BSI
was calculated  for  each  organism.  Bivariable  anal-
yses were  performed  to  determine  the  association
between each  independent  variable  and  CA-BSI
with antibiotic-resistant  versus  antibiotic-sensitive
bacteria  separately  for  each  organism  using  Chi-
square or  Fisher’s  exact  test  for  the  categorical
variables and  Wilcoxon  signed-rank  test  for  the
c
s
(C.M.  Wolfe  et  al.
harlson  comorbidity  index.  For  each  organism,
ndependent variables  associated  with  resistant
A-BSIs at  the  p < 0.25  level  were  included  in  a  mul-
iple logistic  regression  model.  Age  was  assessed
s a  continuous  variable  in  the  regression  model.
inally, we  calculated  the  proportion  of  patients
ith a CA-BSI  who  had  concurrent  urinary  tract,  sur-
ical site,  and  respiratory  infections  with  the  same
rganism.  All  analyses  were  completed  using  SAS
ersion 9.3  (SAS  Institute  Inc.,  Cary,  NC).
esults
haracteristics of patients with CA-BSIs
 total  of  319,959  discharges  occurred  during  the
tudy period,  including  1677  with  CA-BSIs  (5.2
er 1000  discharges).  The  largest  proportion  was
aused by  S.  aureus  (695,  41.4%),  followed  by
nterococcal  species  (333,  19.9%),  K.  pneumo-
iae (332,  19.8%),  S.  pneumoniae  (163,  9.7%),  P.
eruginosa  (84,  5.0%),  and  A.  baumannii  (70,  4.2%;
able  2).  The  majority  of  patients  with  CA-BSIs
ad been  previously  hospitalized  (1072,  63.9%)  and
.7% (112)  previously  resided  in  a skilled  nursing
acility. Nearly  half  of  CA-BSI  patients  had  renal
ailure  (728,  43.4%),  nearly  one-quarter  had  dia-
etes mellitus  (410,  24.5%),  and  malignancies  and
ermatitis were  also  common  (358,  21.3%  and  240,
4.3%, respectively).  Sixteen  percent  (279)  were
ndergoing  dialysis,  7%  (117)  had  received  an  organ
ransplant,  and  only  one  patient  had  a  history  of
rauma at  the  time  of  hospital  admission.  The
argest  proportion  of  infections  occurred  in  the
lderly  >65  years  (634,  37.8%),  and  16.5%  (276)
ccurred  in  pediatric  patients  ≤18  years.
revalence and risk factors for antibiotic
esistance among CA-BSIs
. aureus  had  the  largest  proportion  of  antibi-
tic resistance  (41.2%),  followed  by  enterococcal
pecies (24.3%),  P.  aeruginosa  (20.2%),  S.  pneu-
oniae  (16.6%),  A.  baumannii  (10.0%),  and  K.
neumoniae  (9.9%).  In  the  bivariable  analyses,
here were  no  signiﬁcant  associations  between
esistance and  gender  or  race  for  any  organism
Table  2).  Age  was  signiﬁcantly  associated  with
esistance  for  S.  aureus,  where  age  >65  was  posi-
ively associated  with  resistance  (p  =  0.002),  and  S.iated with  resistance  (p  = 0.03).  Prior  stay  in a
killed nursing  facility  (p  =  0.0002)  and  renal  failure
p =  0.03)  were  signiﬁcantly  positively  associated
Antibiotic-resistant
 com
m
unity-associated
 bloodstream
 infections
 
227
Table  2  Characteristics  of  patients  with  community-associated  antimicrobial-resistant  and  antibiotic-susceptible  bloodstream  infections.
Staphylococcus  aureus Streptococcus  pneuomoniae Pseudomonas  aeruginosa
Resistant Susceptible  p  Resistant  Susceptible  p  Resistant  Susceptible  p
%  (N) 286  409  37  126  17  67
Male  gender 64.0  (183) 61.6  (252) 0.52 54.1  (20)  55.5  (70)  0.87  64.7  (11)  41.8  (28)  0.09
Race  0.57  0.59  —
White  26.6  (76)  25.7  (105)  5.4  (2)  13.5  (17)  29.4  (5)  19.4  (13)
Black  20.3  (58)  15.9  (65)  32.4  (12)  24.6  (31)  5.9  (1)  13.4  (9)
Hispanic  21.3  (61)  23.2  (95)  27.0  (10)  29.4  (37)  11.8  (2)  31.3  (21)
Unidentiﬁed  27.6  (79)  29.8  (122)  32.4  (12)  27.8  (35)  52.9  (9)  31.3  (21)
Other  4.2  (12)  5.4  (22)  2.7  (1)  4.8  (6)  0.0  (0)  4.5  (3)
Age  0.002 0.03 0.09
<5  4.2  (12) 4.4  (18) 10.8  (4) 4.8  (6) 0.0  (0) 10.4  (7)
5—12  1.4  (4)  4.6  (19)  2.7  (1)  0.7  (1)  5.9  (1)  9.0  (6)
13—18  0.3  (1)  3.2  (13)  2.7  (1)  0.7  (1)  0.0  (0)  3.0  (2)
19—35  6.6  (19)  8.8  (36)  10.8  (4)  4.8  (6)  5.9  (1)  4.5  (3)
36—50  19.6  (56)  19.6  (80)  13.5  (5)  22.2  (28)  11.8  (2)  14.9  (10)
51—65  26.6  (76)  28.1  (115)  24.3  (9)  24.6  (31)  29.4  (5)  14.9  (10)
65+  41.3  (118)  31.3  (128)  32.4  (12)  42.0  (53)  47.1  (8)  40.3  (27)
Prior  skilled  nursing
facility  stay
11.9 (34)  2.4  (18)  0.0002  0.0  (0)  4.8  (6)  —  11.8  (2)  3.0  (2)  0.18
Diabetes  31.8  (91)  27.1  (111)  0.18  18.9  (7)  15.9  (20)  0.66  23.5  (4)  16.4  (11)  0.49
Transplant  history  2.8  (8)  6.4  (26)  0.03  5.4  (2)  2.4  (3)  0.32  5.9  (1)  16.4  (11)  0.44
Dialysis  28.7  (82)  20.0  (82)  0.008  16.2  (6)  6.3  (8)  0.10  11.8  (2)  11.9  (8)  1.00
Trauma  0.0  (0)  0.2  (1)  —  0.0  (0)  0.0  (0)  —  0.0  (0)  0.0  (0)  —
Renal  failure  55.2  (158)  46.7  (191)  0.03  37.8  (14)  35.7  (45)  0.81  35.3  (6)  40.3  (27)  0.71
Malignancy  14.0  (40)  18.3  (75)  0.13  13.5  (5)  23.0  (29)  0.21  35.3  (6)  38.8  (26)  0.79
Dermatitis  22.0  (63)  22.7  (93)  0.83  5.4  (2)  7.1  (9)  —  5.9  (1)  7.5  (5)  —
Prior  hospitalizations  67.1  (192)  56.0  (229)  0.003  37.8  (14)  39.7  (50)  0.84  70.6  (12)  80.6  (54)  0.51
Weighted  Charlson
score  (median,  [SE])
2.00 [0.15]  2.00  [0.12]  <0.0001  1.00  [0.47]  2.00  [0.23]  <0.0001  2.00  [0.54]  2.00  [0.29]  <0.0001
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Table  2  (Continued  )
Klebsiella  pneumoniae  Enterococci  species  Acinetobacter  baumannii
Resistant  Susceptible  p  Resistant  Susceptible  p Resistant  Susceptible  p
%  (N)  33  299  81  252  7  63
Male  gender  54.5  (18)  51.8  (155)  0.77  49.4  (40)  57.1  (144)  0.22  28.6  (2)  39.7  (25)  0.70
Race  0.89 0.70 —
White  24.2  (8)  29.8  (89)  29.6  (24)  31.3  (79)  14.3  (1)  22.2  (14)
Black  18.2  (6)  14.7  (44)  11.1  (9)  16.7  (42)  14.3  (1)  30.2  (19)
Hispanic  30.3  (10)  25.4  (76)  23.5  (19)  21.4  (54)  28.6  (2)  25.4  (16)
Unidentiﬁed  21.2  (7)  25.4  (76)  30.9  (25)  27.4  (69)  42.9  (3)  14.3  (9)
Other  6.1  (2)  4.7  (14)  4.9  (4)  3.2  (8)  0.0  (0)  7.9  (5)
Age  0.37 0.21 0.07
<5  15.2  (5) 21.1  (63) 9.9 (8) 10.3  (26) 0.0  (0) 22.2  (14)
5—12 3.0  (1) 6.0  (18) 8.6 (7)  5.6  (11)  0.0  (0)  19.0  (12)
13—18  3.0  (1)  2.3  (7)  1.2  (1)  1.6  (4)  14.3  (1)  0.0  (0)
19—35  9.0  (3)  4.7  (14)  3.7  (3)  4.8  (12)  0.0  (0)  11.1  (7)
36—50  15.2  (5)  12.4  (37)  14.8  (12)  9.5  (24)  14.3  (1)  7.9  (5)
51—65  21.2  (7)  20.1  (60)  23.5  (19)  20.6  (52)  28.6  (2)  17.5  (11)
65+  39.4  (13)  33.8  (101)  39.5  (32)  49.6  (125)  42.9  (3)  22.2  (14)
Prior  skilled  nursing
facility  stay
9.0 (3)  4.0  (12)  0.18  7.4  (6)  10.3  (26)  0.44  0.0  (0)  4.8  (3)  —
Diabetes  24.2  (8)  21.7  (65)  0.74  18.5  (15)  27.8  (70)  0.10  14.3  (1)  11.1  (7)  1.00
Transplant  history  6.1  (2)  10.7  (32)  0.55  11.1  (9)  5.6  (14)  0.09  14.3  (1)  12.7  (8)  1.00
Dialysis  15.2  (5)  8.7  (26)  0.22  14.8  (12)  14.7  (37)  0.99  28.6  (2)  14.3  (9)  0.30
Trauma  0.0  (0)  0.0  (0)  —  0.0  (0)  0.0  (0)  —  0.0  (0)  0.0  (0)  —
Renal  failure  51.5  (17)  36.1  (108)  0.08  39.5  (32)  40.9  (103)  0.83  57.1  (4)  36.5  (23)  0.42
Malignancy  18.2  (6)  28.4  (85)  0.21  27.2  (22)  17.1  (43)  0.05  42.9  (3)  28.6  (18)  0.41
Dermatitis  3.0  (1)  6.0  (18)  0.71  13.6  (11)  11.1  (28)  0.55  0.0  (0)  14.3  (9)  —
Prior
hospitalizations
69.7  (23)  72.2  (216)  0.76  79.0  (64)  65.1  (164)  0.02  57.1  (4)  79.4  (50)  0.54
Weighted  Charlson
score  (median,
[SE])
2.00  [0.24]  1.00  [0.16]  <0.0001  2.00  [0.15]  2.00  [0.28]  <0.0001  2.00  [1.00]  2.00  [0.28]  <0.0001
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Table  3  Factors  associated  with  antibiotic-resistant  versus  antibiotic-susceptible  community-associated  blood-
stream  infection.a
Odds  ratios  (95%  conﬁdence  intervals)
Staphylococcus
aureus  (n  =  695)
Enterococcus  sp.
(n  =  333)
Streptococcus
pneumoniae  (n  =  163)
Prior  stay  in  skilled
nursing  facility
2.55  (1.39—4.70)  —  —
Age  (years)  1.01  (1.002—1.02)  —  0.98  (0.97—0.999)
Malignancy  0.58  (0.37—0.91)  1.82  (1.004—3.30)  —
Prior  hospitalizations  1.62  (1.17—2.23)  2.03  (1.12—3.38)  —
Weighted  Charlson
comorbidity  index
1.09 (1.02—1.17)  —  —
a Results of multiple logistic regression analysis.
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tith  methicillin  resistance  for  S.  aureus,  but  no
igniﬁcant  differences  were  observed  for  other
rganisms, and  the  direction  of  these  associations
as not  consistent  across  organisms.  Transplant  his-
ory was  signiﬁcantly  negatively  associated  with
esistance  for  S.  aureus  (p  =  0.03),  but  this  trend
as also  inconsistent  across  organisms  with  no
ther signiﬁcant  associations  detected.  Prior  hos-
italization  was  signiﬁcantly  positively  associated
ith resistance  for  S.  aureus  (p  = 0.003)  and  ente-
ococcal  species  (p  =  0.02).  Diabetes  was  positively
ssociated with  resistance  for  all  organisms  except
or enterococci  species,  although  these  differences
ere not  statistically  signiﬁcant.  Malignancies  were
ot signiﬁcantly  associated  with  resistance  for  any
rganism,  and  the  direction  of  the  association
etween malignancy  and  resistance  was  not  con-
istent across  organisms.  The  weighted  Charlson
omorbidity index  was  signiﬁcantly  associated  with
esistance  for  all  organisms  (all  p  <  0.001).
In the  multivariable  analyses  (Table  3) for
. aureus,  signiﬁcant  predictors  of  resistance
ncluded previous  residence  in  a  skilled  nursing
acility (OR,  2.55;  95%  CI,  1.39—4.70),  older  age
1.01, 1.002—1.02),  prior  hospitalizations  (1.62,
.17—2.23),  and  weighted  Charlson  comorbidity
ndex (1.09,  1.02—1.17),  while  malignancies  were
rotective  against  resistance  (0.58,  0.37—0.91).
owever, for  enterococcal  species,  malignancies
ere positively  associated  with  resistance  (1.82,
.004—3.30),  along  with  prior  hospitalizations
2.03, 1.12—3.38).  The  only  signiﬁcant  predictor  of
esistance  for  S.  pneumoniae  was  younger  age,  with
1.7% of  isolates  from  patients  <35  years  versus
0% of  those  from  patients  >35  years  resistant  (Chi-
quare,  5.40;  p  = 0.02).  Multivariable  analyses  were
ot performed  for  P.  aeruginosa, A.  baumannii, or
. pneumoniae  due  to  insufﬁcient  power.
i
s
p
soncurrent infections present among
atients admitted with CA-BSIs
ighty-seven  concurrent  infections  were  detected
mong  the  1667  CA-BSI  cases  (Table  4).  Urinary
ract infections  were  the  most  common  concurrent
nfection (n  =  45,  51.7%),  followed  by  respiratory
ract (n  =  30,  34.5%)  and  surgical  site  (n  = 12,  13.8%).
oncurrent  infections  were  most  common  among
atients  with  S.  aureus  BSI  (n  =  62),  followed  by  K.
neumoniae  (n  =  12),  enterococcal  species  (n  =  7),
. aeruginosa  (n  =  3),  A.  baumannii  (n  =  2),  and  S.
neumoniae  (n  =  1).
iscussion
nly  a few  previous  studies  have  investigated
he factors  associated  with  antibiotic  resistance
mong patients  with  a  CA-BSI.  Hattemer  et  al.
14]  examined  differences  between  patients  with
arbapenem-resistant  versus  carbapenem-sensitive
. aeruginosa  CA-BSI  and  reported  no  signiﬁcant  dif-
erences by  age,  sex,  or  Charlson  comorbidity  index
ut did  ﬁnd  that  prior  antibiotic  therapy  was  highly
redictive  of resistance—–a  factor  that  we  were
ot able  to  assess  in  this  analysis.  We  did  ﬁnd  a
ositive, though  not  statistically  signiﬁcant,  associ-
tion between  malignancy  and  antibiotic  resistance
mong  patients  with  enterococcal  infections,  but
his ﬁnding  was  not  consistent  across  all  of the
rganisms we  evaluated.  In  fact,  we  found  that
mong  patients  with  a  CA-BSI  caused  by  S.  aureus,
hose  with  a history  of  malignancy  were  signif-
cantly less  likely  to  have  a methicillin-resistant
train  after  controlling  for  other  factors  such  as
rior hospitalization,  skilled  nursing  facility  stay,
everity of  illness,  and  age.  This  ﬁnding  is  surprising
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Table  4  Concurrent  infections  present  among  patients  admitted  to  hospital  with  community-associated  blood-
stream  infections.a
Bloodstream  infection  organism  (N)  Urinary
tract
infection
(N  =  45)
Pneumonia
(N  =  30)
Surgical
site
infection
(N  = 12)
None
Staphylococcus  aureus Sensitive  (409) 20  (4.9) 12  (2.9)  8  (2.0)  369  (90.2)
Resistant  (286) 6  (2.1) 13  (4.5) 3  (1.1) 264  (92.3)
Streptococcus  pneumoniae Sensitive  (126) 0  (0) 1  (0.8) 0  (0) 125  (99.2)
Resistant  (37)  0  (0)  0  (0)  0  (0)  37  (100)
Pseudomonas  aeruginosa Sensitive  (67)  1  (1.5)  1  (1.5)  0  (0)  65  (97.0)
Resistant  (17)  0  (0)  1  (5.9)  0  (0)  16  (94.1)
Klebsiella  pneumoniae Sensitive  (299)  11  (5.9)  0  (0)  0  (0)  288  (96.3)
Resistant  (33) 1  (3.0) 0  (0)  0  (0)  32  (97.0)
Enterococci  species Sensitive  (252)  5  (2.0)  0  (0)  1  (0.4)  246  (97.6)
Resistant  (81)  1  (1.2)  0  (0)  0  (0)  80  (98.8)
Acinetobacter  baumannii Sensitive  (63) 0  (0) 1  (1.6) 0  (0) 62  (98.4)
Resistant  (7)  0  (0)  1  (14.3)  0  (0)  6  (85.7)
a
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bData are n(%).
but  not  inconsistent  with  a  previous  study  on  ente-
rococcal  bloodstream  infections,  which  found  that
high-level  gentamicin  resistance  was  not  associated
with  all  cancers,  only  hematologic  malignancies
[15].  Methicillin  resistance  is  increasingly  com-
mon among  community  members  without  chronic
illness,  prolonged  contact  with  healthcare  insti-
tutions,  or  other  traditional  risk  factors,  so  the
changing  epidemiology  of  MRSA  might  explain  this
ﬁnding [16].  While  our  study  found  no  differences
in risk  of  resistance  by  race,  Sattler  et  al.  [17]
found  that  among  children  with  an  S.  aureus  CA-BSI,
African  Americans  were  signiﬁcantly  more  likely
and white  and  Hispanic  children  were  signiﬁcantly
less likely  to  have  resistant  isolates;  race  was  the
only signiﬁcant  demographic  or  clinical  predictor  of
resistance  identiﬁed  by  these  authors.  Younger  age
was a risk  factor  for  resistance  in  CA-BSI  caused
by S.  pneumoniae  in  our  patient  population.  This
ﬁnding is not  unexpected  because  pneumococcus
frequently  colonizes  the  respiratory  tract  and  is
particularly  common  in  children,  for  whom  the
tract is  frequently  exposed  to  antimicrobial  agents
[18].
This  study  beneﬁts  from  being  one  of  the  largest
to investigate  the  factors  associated  with  antibiotic
resistance  among  patients  hospitalized  with  a CA-
BSI, though  the  methods  have  certain  limitations.
First, the  use  of  electronic  health  records  limited
our  ability  to  obtain  data  on  patient  symptoms,
so the  case  deﬁnitions  were  primarily  based  on
laboratory  results,  although  the  infection-deﬁning
[

C
ilgorithms  were  validated  by  a  team  of  clinicians
8—10]. Similarly,  the  factors  examined  for  possible
ssociation  with  resistant  CA-BSI  were  restricted
o those  that  could  be  collected  from  patients’
lectronic medical  and  billing  records,  which  are
ot designed  or  validated  for  the  purposes  of
esearch [19].  For  example,  previous  antibiotic
se is  likely  to  be  an  important  risk  factor  for
esistance, but  these  data  were  not  systemati-
ally available  in  the  electronic  medical  records.
rior contact  with  healthcare  facilities  was  also  not
ntirely captured  by  the  available  data  because  the
illing records  only  indicated  previous  admissions
ithin the  hospital’s  network.  A  second  limitation
f this  analysis  was  insufﬁcient  statistical  power
o detect  differences  between  patients  with  resis-
ant versus  susceptible  CA-BSIs  for  some  organisms.
e also  did  not  account  for  possible  polymicrobial
SIs.
The ability  to  identify  which  patients  are  most
ikely to  have  an  infection  with  an  antibiotic-
esistant organism  is  critical,  as  delays  in  effective
ntibiotic therapy  can  drastically  increase  mortal-
ty rates  for  patients  with  a CA-BSI.  One  study  of
atients  with  A.  baumannii  bacteremia  described  a
5% reduction  in  mortality  when  effective  antimi-
robials were  administered  within  48  h  of  an  initial
lood culture  [20]. Similarly,  Apisarnthanarak  et  al.
21]  found  that  patients  with  extended-spectrum
-lactamase-producing  E.  coli  and  K.  pneumoniae
A-BSI had  signiﬁcantly  higher  odds  of  mortal-
ty if  they  did  not  receive  empiric  antimicrobial
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[ntibiotic-resistant  community-associated  bloodstr
herapy  that  included  carbapenem  or  -lactam/-
actamase inhibitors.  Creating  local  or  national  risk
cores, similar  to  what  has  been  done  for  patients
resenting with  community-acquired  pneumonia
22],  could  help  guide  physicians  toward  prescrib-
ng the  most  appropriate  empiric  antibiotics.  The
esults of  this  study  add  to  a  growing  body  of
esearch describing  proﬁles  of  patients  at  highest
isk for  an  antibiotic-resistant  CA-BSI.
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